A Study to Assess Treatment Patterns, Clinical Outcomes and Healthcare Resource Utilization Among Adult Participants With Moderate-To-Severe Plaque Psoriasis
NCT05547490 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3506
Last updated 2023-12-18
Summary
The purpose of this study is to achieve a better understanding of clinical characteristics, treatment patterns and clinical outcomes of participants with moderate-to-severe plaque psoriasis (PsO) as well as their unmet medical needs and disease burden in real-world setting in China.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-10-31
- Primary Completion
- 2023-04-28
- Completion
- 2023-04-28
Countries
- China
Study Locations
More Related Trials
-
A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis
NCT06926582 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque Psoriasis in China
NCT06512337 ·Status: ACTIVE_NOT_RECRUITING
-
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo in Participants With Plaque Psoriasis (POETYK-PSO-3) in Mainland China, Taiwan, and South Korea
NCT04167462 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Study of Efficacy and Safety of AK101 in Subjects With Psoriasis
NCT05120297 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis
NCT00399906 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Effectiveness and Safety of BMS-986322 in Participants With Moderate-to-Severe Psoriasis
NCT05730725 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate the Efficacy and Safety of Netakimab in Chinese Patients With Moderate to Severe Plaque Psoriasis
NCT07008547 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis
NCT05357755 ·Status: COMPLETED ·Phase: PHASE2
-
Real World Study on the Efficacy and Safety of Apremilast in Chinese Patients With Moderate to Severe Plaque Psoriasis, a Multi Center, Prospective, Observational Trial（REACT）
NCT05863273 ·Status: COMPLETED
-
A Real-world Observational Study to Compare Effectiveness of Deucravacitinib Vs Apremilast in Adults With Plaque Psoriasis
NCT05744466 ·Status: RECRUITING
-
Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of ICP-488 in Patients with Moderate to Severe Plaque Psoriasis
NCT06109818 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis
NCT01555606 ·Status: COMPLETED
-
A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis
NCT05364554 ·Status: COMPLETED ·Phase: PHASE2
-
Chinese Psoriasis Real World Evidence Research
NCT04465838 ·Status: RECRUITING
-
A Phase III Study of SYHX1901 Tablets in the Treatment of Moderate to Severe Plaque Psoriasis
NCT06943950 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of HB0017 in Patients With Moderate to Severe Plaque Psoriasis
NCT05531682 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis
NCT07251998 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of Guselkumab (TREMFYA) in Chinese Participants With Moderate to Severe Plaque Psoriasis
NCT04914429 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis
NCT05975268 ·Status: COMPLETED ·Phase: PHASE3
-
Apremilast in Palmo-Plantar Psoriasis
NCT02400749 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of TLL018 in Patients With Plaque Psoriasis
NCT05342428 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis
NCT01483924 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy, Safety, Pharmacokinetics of ICP-488 in Patients With Moderate to Severe Plaque Psoriasis
NCT06842199 ·Status: RECRUITING ·Phase: PHASE3
-
Assessment on Efficacy and Safety of BAT2306 and Cosentyx® in Plaque Psoriasis Patients
NCT05377944 ·Status: COMPLETED ·Phase: PHASE3
-
A Real-world Study to Assess Safety and Effectiveness of Secukinumab in Pediatric Plaque Psoriasis Patients in China
NCT05388916 ·Status: COMPLETED